With recent approvals of semaglutide and resmetirom, the treatment landscape for metabolic dysfunction-associated steatohepatitis (MASH) has entered a new era. In this final webisode of a 4-part CME Outfitters series, expert faculty look ahead to the next wave of therapeutic …
Complicated urinary tract infections (cUTIs) represent an important and growing challenge in clinical practice, affecting individual patients’ health and quality of life while exerting a substantial burden on the healthcare system. Despite being common, these infections are underrecognized. The July …
New guidance from the National Lipid Association emphasizes the need for simpler risk stratification and establishing LDL-C goals. Clinicians have had mixed guidance on LDL-C management and desirable lipid goals until now. We are in a new, more metabolically …
Chronic, subacute, and acute pain remain among the most common and complex challenges encountered in clinical practice. Inadequate pain management contributes to diminished quality of life, impaired function, and increased healthcare utilization. At the same time, the ongoing opioid crisis …
Embark on a one-of-a-kind learning adventure designed to sharpen your diagnostic skills and treatment prowess for primary biliary cholangitis (PBC). In this immersive virtual escape room, you’ll tackle patient case challenges, uncover hidden clues, and piece together the key insights …
